Helping Newborn Babies BreatheStreaming Video - 2016
Curosurf is a clinical treatment for pre-term infants - born before 37 weeks of gestational age - suffering from infant respiratory distress syndrome (RDS), a life-threatening condition of the lungs. Curosurf was developed by Tore Curstedt and Bengt Robertson. Curstedt''s solution relies on a phospholipid extract of natural porcine lungs with the chemical name poractant alfa. Administered through a breathing tube and inserted into the trachea, Curosurf coats infants'' lung alveoli and reduces surface tension, thereby preventing RDS.
Publisher: [Place of publication not identified] : Autentic Distribution GmbH, 
Copyright Date: ©2016
Branch Call Number: E-VIDEO
Characteristics: 1 online resource (1 video file (7 min., 52 sec.)) : sound, color. video file, rda digital, rda